Celltrion, Inc. Stock OTC Markets
Stocks
CONIF
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 46,095B 32.6B 28.15B 26.41B 24.05B 45.22B 3,117B 45.85B 310B 121B 1,562B 122B 120B 5,195B | P/E 2026 * |
30.6x | P/E 2027 * | 26.4x |
|---|---|---|---|---|---|
| Enterprise Value | 48.07B 34M 29.35M 27.54M 25.08M 47.16M 3.25B 47.82M 323M 127M 1.63B 128M 125M 5.42B | EV / Sales 2026 * |
8.82x | EV / Sales 2027 * | 7.49x |
| Free-Float |
58.26% | Yield 2026 * |
0.38% | Yield 2027 * | 0.41% |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 20/03/2015 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 26/03/2021 |
Hyeok-Jae Lee
PSD | President | 50 | 13/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 68 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 01/04/2005 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 32.61B | |
| +0.68% | -1.01% | +2.16% | +18.05% | 48.42B | |
| +4.07% | +3.34% | +483.70% | +609.03% | 43.66B | |
| +4.33% | +4.09% | +12.80% | +88.48% | 39.51B | |
| +1.94% | +1.06% | +26.24% | +12.10% | 38.95B | |
| -0.50% | +0.85% | +20.60% | +58.18% | 32.61B | |
| -0.44% | -3.14% | - | - | 16.32B | |
| +3.22% | +1.09% | +30.42% | +133.64% | 16.15B | |
| -0.62% | +0.29% | +3.46% | +25.58% | 14.16B | |
| +2.35% | +7.16% | +82.95% | +41.92% | 13.37B | |
| Average | +1.51% | -0.35% | +82.79% | +123.37% | 29.24B | |
| Weighted average by Cap. | +1.73% | -0.62% | +101.58% | +147.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,449B 3.85B 3.33B 3.12B 2.84B 5.35B 369B 5.42B 36.59B 14.34B 185B 14.47B 14.16B 614B | 6,325B 4.47B 3.86B 3.62B 3.3B 6.21B 428B 6.29B 42.47B 16.64B 214B 16.8B 16.43B 713B |
| Net income | 1,485B 1.05B 907M 851M 775M 1.46B 100B 1.48B 9.97B 3.91B 50.32B 3.94B 3.86B 167B | 1,768B 1.25B 1.08B 1.01B 923M 1.73B 120B 1.76B 11.87B 4.65B 59.91B 4.7B 4.59B 199B |
| Net Debt | 1,978B 1.4B 1.21B 1.13B 1.03B 1.94B 134B 1.97B 13.28B 5.2B 67.01B 5.25B 5.14B 223B | 1,262B 893M 771M 723M 659M 1.24B 85.38B 1.26B 8.48B 3.32B 42.78B 3.35B 3.28B 142B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
